Value Bridge — COXHEALTH
Current $-105M → Target $-75M (+$30.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-105.3M
Current EBITDA
$-74.8M
Target EBITDA
+$30.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$6.9M
Payer Mix Optimization
$16.5M
Cost to Collect Reduction
$5.5M
Clean Claim Improvement
$4.1M
Volume & Rate Growth
$27.6M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-105M to $-75M. The highest-impact lever is Volume & Rate Growth at $11.0M probability-weighted.
IC talking point: "We see $30M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $335M in equity value creation."